| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS ORD (NMS) | 25,000 | 342,000 | 0.02% | ||
| 2 | INFINITY PHARMACEUTICALS INC | 270,000 | 421,000 | 0.03% | ||
| 3 | OREXIGEN THERAPEUTICS INC | 165,300 | 549,000 | 0.03% | ||
| 4 | CERULEAN PHARMA INC | 625,000 | 654,000 | 0.04% | ||
| 5 | MADRIGAL PHARMACEUTICALS INC | 63,000 | 799,000 | 0.05% | ||
| 6 | WRIGHT MED GROUP INC SR CONV NT 2 20 | 1,000,000 | 1,073,000 | 0.07% | PRN | |
| 7 | INSYS THERAPEUTICS INC NEW COM NEW | 100,000 | 1,179,000 | 0.07% | ||
| 8 | CERNER CORP | 20,000 | 1,235,000 | 0.08% | ||
| 9 | BLUEBIRD BIO INC COM | 20,000 | 1,356,000 | 0.09% | ||
| 10 | Life Technologies Corp | 433,500 | 1,379,000 | 0.09% | ||
| 11 | ANTHERA PHARMACEUTICALS I | 450,000 | 1,418,000 | 0.09% | ||
| 12 | CHIASMA INC | 492,500 | 1,448,000 | 0.09% | ||
| 13 | EXELIXIS INC | 125,000 | 1,599,000 | 0.10% | ||
| 14 | VALEANT PHARMACEUTICALS INTL | 68,600 | 1,684,000 | 0.11% | ||
| 15 | DYNAVAX TECHNOLOGIES CORP | 165,000 | 1,731,000 | 0.11% | ||
| 16 | NOVAVAX INC COM | 852,500 | 1,773,000 | 0.11% | ||
| 17 | NOVOCURE LTD | 214,316 | 1,830,000 | 0.11% | ||
| 18 | DIMENSION THERAPEUTICS INC | 271,370 | 2,168,000 | 0.14% | ||
| 19 | AMSURG CORP | 32,500 | 2,179,000 | 0.14% | ||
| 20 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 98,000 | 2,259,000 | 0.14% | ||
| 21 | Egalet Corp | 300,000 | 2,283,000 | 0.14% | ||
| 22 | SCYNEXIS INC | 635,000 | 2,457,000 | 0.15% | ||
| 23 | GENOCEA BIOSCIENCES INC | 480,000 | 2,458,000 | 0.15% | ||
| 24 | TETRAPHASE PHARMACEUTICALS INC COM | 662,500 | 2,537,000 | 0.16% | ||
| 25 | DBV TECHNOLOGIES S A | 73,000 | 2,652,000 | 0.17% | ||
| 26 | SERES THERAPEUTICS INC | 220,000 | 2,704,000 | 0.17% | ||
| 27 | ASSEMBLY BIOSCIENCES INC | 390,000 | 2,812,000 | 0.18% | ||
| 28 | CIDARA THERAPEUTICS INC | 250,000 | 2,863,000 | 0.18% | ||
| 29 | INTRA-CELLULAR THERAPIES INC | 190,000 | 2,896,000 | 0.18% | ||
| 30 | STERIS PLC SHS USD | 40,000 | 2,924,000 | 0.18% | ||
| 31 | ADR - Nabriva Therapeutics AG- Usd | 426,000 | 3,003,000 | 0.19% | ||
| 32 | MEDNAX INC | 50,000 | 3,313,000 | 0.21% | ||
| 33 | AEGLEA BIOTHERAPEUTICS INC | 524,089 | 3,359,000 | 0.21% | ||
| 34 | PERRIGO CO PLC | 37,900 | 3,499,000 | 0.22% | ||
| 35 | INNOVIVA INC COM | 336,900 | 3,703,000 | 0.23% | ||
| 36 | CARDIOME PHARMA CORP | 1,200,000 | 3,751,000 | 0.24% | ||
| 37 | Otonomy Inc | 210,000 | 3,820,000 | 0.24% | ||
| 38 | MEDICINES CO SR GLBL CV NT 22 | 3,000,000 | 3,898,000 | 0.24% | PRN | |
| 39 | Nivalis Therapeutics Inc | 489,000 | 3,976,000 | 0.25% | ||
| 40 | MEDPACE HLDGS INC | 135,000 | 4,031,000 | 0.25% | ||
| 41 | ALLERGAN PLC | 5,000 | 4,106,000 | 0.26% | ||
| 42 | BIOSCRIP INC | 1,490,492 | 4,308,000 | 0.27% | ||
| 43 | AIMMUNE THERAPEUTICS INC COM | 293,000 | 4,395,000 | 0.28% | ||
| 44 | KITE PHARMA INCORPORATED | 79,000 | 4,413,000 | 0.28% | ||
| 45 | CHINA CORD BLOOD CORP | 880,000 | 4,497,000 | 0.28% | ||
| 46 | CLOVIS ONCOLOGY INC | 125,000 | 4,506,000 | 0.28% | ||
| 47 | TANDEM DIABETES CARE INC COM | 595,000 | 4,558,000 | 0.29% | ||
| 48 | PUMA BIOTECHNOLOGY | 69,500 | 4,660,000 | 0.29% | ||
| 49 | ADAPTIMMUNE THERAPEUTICS PLC | 675,000 | 4,759,000 | 0.30% | ||
| 50 | FIBROGEN INC | 233,500 | 4,833,000 | 0.30% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-004294, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
